Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant (Pleural) Mesothelioma |
| Start Date: | October 1, 2009 |
| Phase: | Phase I |
| Status: | Recruiting |
| NCT ID: | NCT01241682 |
| Study Type: | Interventional |
| Intervention: | Biological: DC + CTX |
| Study Design: | Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Erasmus Medical Center |
| Ages: | Child|Adult|Senior |
| Enrollment: | 10 |
| Funded By: | Other |
| First Received: | June 1, 2010 |
| End Date: | October 1, 2012 |
| Last Updated: | November 15, 2010 |
| Last Verified: | November 1, 2010 |